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Summary: A randomly chosen population in the area of Westphalia (West Germany) was screened for apo-
lipoprotein A-I mutants. About 5000 individuals were investigated and compared with a group of 1300
patients who had undergone coronary angiography. Four electrophoretically different apolipoprotein A-I-
mutants (named Münster-1 to 4) were discovered. Five non-related probands were observed in the group of
the unselected patients and three non-related probands in the group of coronary angiography patients. In
most cases the familial nature of the abnormality was confirmed by pedigree analysis.
Zur Häufigkeit von Apolipoprotein A-I-Mutanten in der deutschen Bevölkerung
Zusammenfassung: Eine Bevölkerungsgruppe von 5000 Personen in Westfalen sowie eine Gruppe von 1300
koronarangiographierten Personen wurde mittels isoelektrischer Fokussierung von Nativserum auf Apolipo-
protein A-I-Mutanten untersucht. Es wurden bei insgesamt 8 Probanden (davon 5 in der Gruppe der zufällig
ausgewählten Patienten und 3 in der Gruppe der koronarangiographierten Patienten) 4 isoelektrisch ver-
schiedene Mutanten (genannt Münster-1 bis 4) gefunden. In den meisten Fällen wurde das familiäre Vorlie-
gen der Mutation mittels Stammbaumanalyse bestätigt.
Introduction
Many apolipoprpteins exist in electrophoretically
different forms. This has been shpwn for apolipopro-
tein E (1), apolipoprotein A-IV (2), and apolipopro-
tein C-II (3). For apolipoprotein E and A-IV these
mutant forms occur rather commonly in the normal
population with a frequency of 1—2% for the homo-
zygous state (l, 2). In the case of apolipoprotein A-I
only a few rare cases of mutations have been de-
scribed, e.g. A-I-Milano (4, 5), A-I-Marburg and
A-I^Gießen (6), and A-I-Münster 1-3 (7).
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The occurrence of apolipoprotein mutations could
give new Information about the function of normal
apolipoproteins in lipid metabolism, äs already dem-
onstrated for apolipoprotein E (8). Since a malfunc-
tion of lipid metabolism might also be related to car-
diovascülar disease (9), we investigated the occur-
rence of apolipoprotein A-I mutations in both an un-
selected population, and in a group of patients with a
history of coronary artery disease.
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Materials and Methods
P a t i e n t s
Sera from paticnts wcre collectcd in connection with a prospective
cardiovascular study in the area of Westphalia, West Germany
(10). Sera of paticnts who had undergone coronary angiography
were supplied by the Department of Cardiology, University of
Düsseldorf, West Germany. Either fresh or frozen (-20 °C) sera
were used.
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I soe lec t r ic focus ing
The serum was incubated in the presence of decylsulphate and ß-
mercaptoethanol and subjected to isoelectric focusing in a pH gra-
dient from 4-6 (7). After focusing overnight the gels were stained
with Coomassie brillant blue.
For two dimensional immunelectrophoresis the gel Strips were cut
after isoelectric focusing, and agarose containing specific anti apo-
lipoprotein A-I antibodies (Beh ringwerke, Marburg) was poured
onto a plastic cover around the Strips. After electrophoresis the
plates were washed, and the immunoprecipitates stained with
Coomassie (7). Lipoproteins were isolated by ultracentrifugation
according to Havel et al. (11).
A f f
Cyanogen bro'mide hydro lys i s
For analytical purposes, the pure apolipoprotein A-I isoforms
were precipitated with 100 g/l trichloroacetic acid to remove the
ampholytes and washed 3 times with 100 g/l trichloroacetic acid at
0 °C. The trichloroacetic acid was removed from the precipitated
protein by ice-cold acetone. The protein was solubilized in 10 g/l
formic acid and 10 g/l decylsulphate and CNBr was added in a
500-fold molar excess over the methionine content (1500 molar
ratio to apolipoprotein A-I) and incubated for 24 h at 25 °C. The
CNBr peptides were lyophilized and subjected to isoelectric foc-
using in a pH gradient of 3.5 to 10. After Separation by isoelectric
focusing, the peptides were analysed in the second dimension by
sodium dodecyl sulphate gel electrophoresis to determine their
molecular weight.
Results
Isoelectric focusing of normal serum in a pH gra-
dient from 4—6 reveals up to 15 bands, of which the
most predominant one is apolipoprotein A-I (fig. l,
lanes A and K). In addition to the major isoform of
apolipoprotein A-I (apolipoprotein A-I-1), which
accounts for about 90% of total apolipoprotein A-I,
a minor isoform (apolipoprotein A-I-2) with a serum
concentration of about 8% of total apolipopro-
tein A-I is also observed (9).
In addition to these normal isoforms of apolipopro-
tein A-I, we detected some rare cases of electrophö-
retic variants of apolipoprotein A-I (fig. l, lanes B to
J). Identification äs apolipoprotein A-I was based
upon molecular weight determination by SDS elec-
trophoresis, immunoreactivity against monospecific
apolipoprotein A-I antibodies in two-dimensional
immunoelectrophoresis and amino acid analysis.
We distinguished between four electrophoretically
different mutants, designated apolipoprotein A-I-
Münster-1 to apolipoprotein A-I-Münster-4. As
Fig. l. Isoelectric focusing of normal serum (A, K) and serum of
patients with apolipoprotein A-I^Münster variants (B—J).
A-I, A-II, A-IV = Apolipoprotein A^I, A-II, A-IV.
evaluated by two-dimensional immunoeiectrophore-
sis, the serum concentrations of the normal apolipo-
protein A-I and the mutant apolipoprotein A-I were
usually similar. In 5 families (table l, proband l, 2,
3, 5, 7) the apolipoprotein variant was observed in
several family members. In 3 families (4, 6, 8), no
evidence for the familial nature of the mutation
could be established, owiii'g to tKe limited number of
first-degree relatives available for investigation.
Isoelectric focusing of the serum of the proband af-
fected by the apolipoprotein A-I-Münster-1 variant
(F.Fr.) reveals two apolipoprotein A-I bands very
close to each other (fig. l, lane B), the upper being
the normal apolipoprotein A-I, the lower being the
mutant apolipoprotein A-I-Münster-1. This muta-
tion was observed in a single family. The apolipopro-
tein A-I-Münster-2 variant, which migrates in the
Position of apolipoprotein A-I-2 (minor isoform of
apolipoprotein A-l-1), was observed in three non^
related probands (fig. l, lanes C, D and F). Probands
with the more basic mutant apolipoprotein A-I-
Münster-3 were also observed in three non^related
probands (fig. l, lanes E, G and J). The apolipopro-
tein A-I-Münster-2 variant and apolipoprotein A-I-
Münster-3 variant differ by l Charge unit (-^1 and
-hl, respectively) ffom normal apolipoprotein A-I.
Only one proband was discovered with a mutant
» apolipoprotein A-I which differed by two Charge un-
its from normal apolipoprotjbin A-I (äpolipopfo-
tein A-I-Münster-4) (fig. l, lane H).
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Tab. 1. Some characteristics of the eight detected probands suffering from apolipoprotein -l mutants.
Proband
l.F.Fr.
2.G.Fu.
3. CD.
4. G.E.
5. H.H.
6. M. K.
7. H.B.
8. A. R.
Mutant
AI Münster- 1
AI Münster-2
AI Münster-2
AI Münster-2
AI Münster-3
AI Münster-3
AI Münster-3
AI Münster-4
Affected
CNBr fragment
CB-4
CB-4
CB-2
CB-2
CB-1
CB-2
CB-4
CB-4
Age
(a)
47
22
54
48
56
38
27
37
Affected family
members
(N)
10 (23)*
4 (4)
9(23)
1 0)
5 (9)
1 (3)
4 (5)
1 (D
Cholesterol
(mmol/1)
6.83
4.97
5.22
9.54
5.51
4.50
5.25
7.89
Triglycerides
(mmol/l)
3.47 '
1.78
1.02
2.98
2.61
0.83
1.05
0.79
HOL
Cholesterol
(mmol/1)
0.98
0.91
1.34
1.09
0.91
1.32
1.06
1.11
* The numbers in brackets indicate the numbers of first degree relatives investigated.
In each case the affected CNBr fragment was identi-
fied by isoelectric focusing of the apolipoprotein A-
I-CNBr-peptides (fig. 2). As summarized in table l,
probands 2 and 3, which are both affected by the
apolipoprotein A-I-Münster-2 variant, do not share
the same molecular defect. Similarly, probands 5, 6
and 7, all affected by the apolipoprotein A-I-Müns-
ter-3 variant, exhibit the amino acid defect in differ-
ent CNBr-peptides.
In the group of 5000 non-selected individuals we de-
tected two probands with the apolipoprotein A-I-
Münster-2 variant, two probands with the apolipo-
protein A-I-Münster-3 variant and one with apo-
lipoprotein A-I-Münster-4 variant. The other pro-
bands affected by apolipoprotein A-I variants were
observed in the group of coronary angiography pa-
tients. Owing to the limited number of probands in
the group of coronary angiography patients it is diffi-
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Fig. 2. Isoelectric focusing of the cyanpgen bromide (CB) peptides from the apolipoprotein A-I-Münster-3 (A-l-Mü-3) from individuals
M.K. and H.H. (A, C), from the apolipoprotein A-I-Münster-2 (A-I-Mü-2), from individual G.E. (F) and from control persons
(B, D, E).
Isoelectric focusing was performed in a pH gradient of 3.5 to 10. The nomenclature of cyanogen bromide peptides is according to
Brewer et al. (14), and identification was based on the molecular weight determination (second dimension, SDS gels, not shown)
and on the isoelectric focusii>g position.
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cult to ascertain whether or not the apolipoprotein
mutation relates to the occurrence of coronary heart
disease. In the case of the apolipoprotein A-I-Mün-
ster-1 variant (F.Fr.) the proband and his affected
brother both had developed severe premature coro-
nary artery disease, but they were also E 2/2 homo-
zygotes with slightly elevated lipid values. One pa-
tient affected by the apolipoprotein A-I-Münster-2
variant (C.D.) had heart valve failure, whereas the
patient with apolipoprotein A-I-Münster-3 variant
(H. H.) suffered from premature coronary artery dis-
ease.
A-I-1-MCK - -
A-I-2-MÜ-4 - -2-
U
I I
A-I-1-N l
A-I-1-MÜ-2* A-I-2-N
n r
A-FI-N l
· ·1· -2+ *2·
Fig. 3. Crossed immunoelectrophoresis after isoelectric focusing
against anti-apolipoprotein A-I (7).
a) apolipoprotein A-l-Münster-4 variant, native serum
b) apolipoprotein A-I-Münster-2 variant, native serum,
patient G.Fu.
c) apolipoprotein A-I-Münster-2 variant, ultraceritrifu-
gally isolated HOL, patient G.Fu.
Information was also obtained about the ability of
the various apolipoprotein A-I-mutants to express
normal function with respect to lipid binding and/or
protein-protein interaction within high density lipo-
proteins (HDL). The ratio of the normal and mutant
apolipoprotein A-I was determirfed in serum äs well
äs HDL by two-dimensional immuiio-electrophore-
sis; in nearly all cases the ratio was about 1:1 in both
native serum and HDL. This is demonstrated for the
apolipoprotein A-I-Münster-4 variant in figure 3. In
contrast to these regulär findings in one family with
the apolipoprotein A-I-Münster-2 variant, the na^
tive sera of the affected family members exhibit a
ratio of 5:3 (normal to rnutant apolipoprotein A-I)
and the HDL exhibit a ratio of 7:2 (fig. 3, b and c).
Preferential displacement of the mutant apolipopro-
tein A-I-Münster-2 (proband Q.Fu.) ffom HDL ap-
parently occurred during ultracentrifugal isolation,
äs evidenced by the 2:7 ratio (normal to mutant apo-
lipoprotein A-I) in the d > 1.21 kg/l ultracentrifugal
fraction (not shown).
Discussion
With the isoelectric focusing technique described
here four different electrophoretic mutants of apo-
lipoprotein A-I occurring in eight non-related pro-
bands were discovered in a screening program in-
volving approx. 6300 patients. Since different point
mutations may cause an identical Charge shift, mo-
lecular heterogeneity withiti eäch of the Münster
variants can be predicted. This was demonstrated by
CNBr peptide analysis of the Münster-2 and Mün-
ster-3 variants äs indicated in table 1.
Discovery of these apolipoprotein A-I mutants is of
great interest for the further understanding of struc-
türe-function relationships of this äpolipoprotein.
Isolated normal apolipoprotein A-I häs the cäpacity
to bind phospholipid, to reassociate with HDL, and
to activate the enzyme lecithin-cholesterol aeyltrans-
ferase (12). The molecular requirements. of phos-
pholipid binding relate to hydrophobic interaction of
the fatty acid moiety and hydrophobic surface areas
of amphipathic helices within the apolipoprotein.
The molecular requirerhents of reassociation of apo-
lipoprotein A-I with HDL äs well äs lecithin-choles-
terol acyltransferase activation are less well under-
stood (13).
It was of interest to notice that in one family affected
• by the Münster-2 variant the mutant apolipopro-
tein A^I occurred in lower s;erum conceritrations
than the normal apolipoprotein. This discrepancy
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was more pronounced in ultracentrifugally isolated
HDL, suggesting that the mutant apolipoprotein A-I
was more vulnerable to displacement.
A detailed study of the precise molecular defect in
the various apolipoprotein A-I mutants has now
been performed. Preliminary sequence Information
suggests that two of the Münster-3 variants are
caused by different molecular defects. In proband 5
an amino acid exchange was observed in position 4
(Pro —> Arg), whereas in proband 6 the Charge dif-
ference of the mutant apolipoprotein A-I is due to
Asp —» Asn exchange in position 103 (15). In two
non-related probands affected by the Münster-2 var-
iant a lysine deletion was noticed in position 107
(Rall, S. & Mahley, R. W., personal information).
However, these preliminary sequence data relate at
present only to the electrophoretically abnormal
CNBr peptides and füll sequence analysis or DNA
analysis may be required to exclude the possibility of
the existence of further structural changes relevant
to functional abnormalities.
Whether or not certain apolipoprotein A-I mutants
may cause abnormalities of lipoprotein metabolism
is currently under investigation. Due to the limited
nuinber of affected families and the possible coexist-
ence of other lipid-modifying genetic defects, such
functional data are difficult to obtain. In particular,
the possible relationship of apolipoprotein A-I mu-
tants to the development of coronary artery disease
requires much further information. Nevertheless, it
can be anticipated that detailed further structural
knowledge of these mutants will give a clue äs to the
critical domains in the primary structure of apolipo-
protein A-I.
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